12-24 Hours
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this
Aproxi 125
Beacon Pharmaceuticals PLC
Generic: Aprepitant
Safety Advices
বাংলা
English
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Aproxi 125. Please consult your doctor.
CONSULT YOUR DOCTOR
Aproxi 125 may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Aproxi 125 is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
UNSAFE
Aproxi 125 may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
SAFE IF PRESCRIBED
Aproxi 125 is safe to use in patients with kidney disease. No dose adjustment of Aproxi 125 is recommended.
SAFE IF PRESCRIBED
Aproxi 125 is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Aproxi 125 may not be needed in these patients. Please consult your doctor.
Medicine Overview of Aproxi 125mg Capsule
Introduction
Aproxi 125 is a prescription medicine used to prevent nausea and vomiting caused by chemotherapy. It is also used in the prevention of postoperative nausea and vomiting in adults. Aproxi 125 is given by your doctor or nurse. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your doctor know about all other medications you are taking as some may affect, or be affected by this medicine. The most common side effects are headache, hiccups, loss of appetite, fatigue,...
... Show moreUses of Aproxi 125
- Nausea and vomiting due to chemotherapy
Side effects of Aproxi 125
Common
- Headache
- Dizziness
- Hiccup
- Loss of appetite
- Fatigue
- Constipation
How to use Aproxi 125
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Aproxi 125 works
Aproxi 125 is an antiemetic medication. It works by blocking the action of a chemical messenger (neurokinin) in the brain that may cause nausea and vomiting during anti-cancer treatment (chemotherapy).
What if you forget to take Aproxi 125?
If you miss a dose of Aproxi 125, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Quick Tips
- Aproxi 125 helps prevent nausea and vomiting caused by certain chemotherapy medicines.
- It will not help if you already have nausea and vomiting.
- Do not use it continuously for a long time.
- It is recommended to take Aproxi 125 1 hour before chemotherapy treatment (Day 1) and in the morning on Days 2 and 3.
- It may damage sperms and may harm the baby if used during pregnancy or breastfeeding.
Brief Description
Indication
Prevent nausea and vomiting caused by certain types of cancer medicines (chemotherapy), prevent nausea and vomiting after surgery.
Administration
May be taken with or without food.
Adult Dose
Prevention of Postoperative Nausea and Vomiting
Adults
PO 40 mg within 3 h prior to induction of anesthesia.
Prevention of Chemotherapy–Induced Nausea and Vomiting
PO 125 mg 1 h prior to chemotherapy treatment on day 1 and 80 mg/day in the morning on days 2 and 3. Administer in combination with a corticosteroid and 5-HT 3 antagonist.
Use with caution in Moderate to severely decreased liver function.
Child Dose
Capsule: Aged <12 years and weight <30 kg: Safety and efficacy not established
Contraindication
Coadministration of astemizole, cisapride, pimozide, or terfenadine; hypersensitivity to any component of the product.
Mode of Action
Aprepitant is an antiemetic which acts as a substance P/neurokinin 1 (NK1) receptor antagonist. It also enhances antiemetic activity of 5HT3 antagonists and corticosteroid.
Precaution
This medicine could make hormonal contraceptives, eg the pill, mini-pill or patch less effective at preventing pregnancy. If you are using hormonal contraceptives, you should use an extra back-up method of contraception, eg condoms, to prevent pregnancy, both during treatment with this medicine and for two months after the last dose.
Lactation: It is not known whether this drug is excreted in milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Side Effect
>10% (only seen in CINV)
Headache,Asthenia/fatigue,Anorexia,Constipation,Diarrhea,Nausea,Alopecia,Hiccups
1-10% (selected)
Dizziness,Insomnia,Bradycardia,Hypotension,Pharyngolargeal pain,Mucosal inflammation,Stomatitis,Dyspepsia,Anemia,Neutropenia,Hot flash,Pruritus,Dehydration,Fever
Pregnancy Category Note
Pregnancy Insufficient data on use in pregnant women to inform a drug associated risk; in animal reproduction studies, no adverse developmental effects observed in rats or rabbits exposed during period of organogenesis to systemic drug levels (AUC) ~1.5 times adult human exposure at 125-mg/80-mg/80-mg regimen Avoid use of aprepitant IV emulsion in pregnant women due to the alcohol content Coadministration with aprepitant may reduce the efficacy of hormonal contraceptives; advise females of reproductive potential using hormonal contraceptives to use an effective alternative or back-up non-hormonal contraceptive (such as condoms or spermicides) during treatment and for 1 month following the last...
... Show moreInteraction
Concurrent use with CYP3A4 inhibitors (e.g. clarithromycin, troleandomycin, diltiazem, verapamil, itraconazole, ketoconazole, nefazodone, ritonavir, nelfinavir) may lead to increased plasma levels of Aprepitant; concurrent use with CYP3A4 inducers (e.g. carbamazepine, phenytoin, rifampicin, primidone, phenobarbital) may lead to reduced efficacy of Aprepitant. May decrease concentrations of CYP2C9 substrates e.g. phenytoin, tolbutamide, warfarin. May increase plasma levels of dexamethasone and methylprednisolone. May increase plasma levels of benzodiazepine (e.g. midazolam, diazepam, alprazolam). Serum concentrations of colchicine may increase with Aprepitant. May increase toxicity of chemotherapy drug metabolised by CYP3A4 e.g. docetaxel, etoposide, ifosfamide, imatinib, paclitaxel, vincristine, vinblastin. May increase levels of ergot derivatives...
... Show moreব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register